As active pharmaceutical ingredients or drug substances become more targeted and potent, many of these compounds will fall into either a Category 4 or 5 control band.

These compounds may be called highly potent compounds, and in order to prevent occupational exposure, these highly potent compounds require significant engineering and administrative controls, and, as a tertiary means of protection, personal protective equipment.

Affygility Solutions is pleased to present our newest web seminar on Category 4 and 5 compounds: Manufacturing Highly Potent Compounds: Understanding and Controlling the Risks. Upon completion of this 2-hour webinar, each participant will be able to:

• Understand the toxicological criteria that can cause an active pharmaceutical ingredient or drug substance to be classified as a highly potent compound
• Describe why occupational exposure limits alone are not enough to determine if a potent compound or drug substance is a highly potent compound
• Describe the types of engineering and administrative controls necessary to prevent occupational exposure to highly potent compounds
• Describe the necessity for containment validation and surrogate monitoring prior to the processing or handling of the actual highly potent compound
• Describe several case histories, where occupational exposure to highly potent compounds have caused unintended health effects in workers
• Provide several examples of highly potent compounds

Taught by industry experts, with decades of experience, and using the latest in online training technology, participants will have the ability to ask the instructors specific questions.

Space is limited, so register today for this important webinar. Cost for this course is $159 USD per attendee. Group discounts are available.

1. Home
2. Training
3. Manufacturing Highly Potent Compounds: Understanding and Controlling the Risks